These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30146355)

  • 1. Population-based colorectal cancer screening: Interval cancers and relationship with the quantitative faecal immunological for hemoglobin.
    Burón A; Macià F; Andreu M; Pellisé M; Castells X; Grau J
    Med Clin (Barc); 2019 Apr; 152(8):303-306. PubMed ID: 30146355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test.
    Moss SM; Hardcastle JD; Coleman DA; Robinson MH; Rodrigues VC
    Int J Epidemiol; 1999 Jun; 28(3):386-90. PubMed ID: 10405838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.
    Cha JM; Suh M; Kwak MS; Sung NY; Choi KS; Park B; Jun JK; Hwang SH; Lee DH; Kim BC; Lee YK; Han DS
    Am J Gastroenterol; 2018 Apr; 113(4):611-621. PubMed ID: 29610512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).
    Portillo I; Arana-Arri E; Idigoras I; Bilbao I; Martínez-Indart L; Bujanda L; Gutierrez-Ibarluzea I
    World J Gastroenterol; 2017 Apr; 23(15):2731-2742. PubMed ID: 28487610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening. Faecal occult blood tests.
    McDonald C
    Aust Fam Physician; 1985 Apr; 14(4):273, 276-7. PubMed ID: 4015528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].
    Domènech X; Garcia M; Benito L; Binefa G; Vidal C; Milà N; Moreno V
    Gac Sanit; 2015; 29(6):464-71. PubMed ID: 26341155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
    BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case for colorectal cancer screening in Singapore.
    Goh HS
    Ann Acad Med Singap; 1989 Jan; 18(1):90-2. PubMed ID: 2712526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval cancers in a community-based programme of colorectal cancer screening with faecal occult blood test.
    Tazi MA; Faivre J; Lejeune C; Bolard P; Phelip JM; Benhamiche AM
    Eur J Cancer Prev; 1999 Apr; 8(2):131-5. PubMed ID: 10335459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
    Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
    J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A control trial of faecal occult blood screening for colorectal cancer: 2-year results.
    Hardcastle JD; Armitage NC; Chamberlain J; Balfour TW; Amar SS
    Br J Surg; 1985 Sep; 72 Suppl():S69-71. PubMed ID: 3899267
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
    Winawer SJ; Fleisher M
    Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria.
    Jahn B; Sroczynski G; Bundo M; Mühlberger N; Puntscher S; Todorovic J; Rochau U; Oberaigner W; Koffijberg H; Fischer T; Schiller-Fruehwirth I; Öfner D; Renner F; Jonas M; Hackl M; Ferlitsch M; Siebert U;
    BMC Gastroenterol; 2019 Dec; 19(1):209. PubMed ID: 31805871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy.
    Giorgi Rossi P; Carretta E; Mangone L; Baracco S; Serraino D; Zorzi M;
    J Med Screen; 2018 Mar; 25(1):32-39. PubMed ID: 28195508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of colorectal cancer: a review.
    Hardcastle JD; Armitage NC
    J R Soc Med; 1984 Aug; 77(8):673-6. PubMed ID: 6384511
    [No Abstract]   [Full Text] [Related]  

  • 17. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epidemiological study evaluating the relationship of distance from a tertiary care cancer center to early detection of colorectal carcinoma.
    Koka VK; Potti A; Fraiman GN; Hanekom D; Hanley JF
    Anticancer Res; 2002; 22(4):2481-3. PubMed ID: 12174948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.